Understanding low chemoprevention uptake by women at high risk of breast cancer: findings from a qualitative inductive study of women’s risk-reduction experiences

Table 3 Awareness of Chemoprevention and Access to Risk-Reduction Information

	Aware of chemoprevention	Unaware of chemoprevention	Total^a
Has never seen a relevant specialist^b	7 (27%)	19 (73%)	26 (55%)
Has seen at least one relevant specialist^b	14 (67%)	7 (33%)	21 (45%)
Has ongoing contact with at least one specialist^b	10 (71%)	4 (29%)	14 (30%)
Main source of risk-related information is a healthcare provider^b	13 (65%)	7 (35%)	20 (43%)
Main source of risk-related information is not a healthcare provider^b	8 (30%)	19 (70%)	27 (57%)
Has discussed risk-reduction with a healthcare provider^b	11 (85%)	2 (15%)	13 (28%)
Has never discussed risk-reduction with a healthcare provider^b	10 (29%)	24 (71%)	34 (72%)
Total^b	21 (45%)	26 (55%)	47 (100%)

All categories coded inductively from qualitative data. For example, a woman was coded as “has not seen a relevant specialist” if her entire narrative about how she has learned, thought, and decided about breast cancer prevention includes no mention of ever having seen a breast specialist, oncologist, or genetic specialist about anything related to her breast cancer risk
^aNumbers in this column are row totals. Percentages are out of the sample of 47 participants analyzed in this paper
^bPercentages on this row refer to the percent of the row total that falls in this column (e.g. 67% of those who have seen at least one relevant specialist are aware of chemoprevention)

ISSN: 1472-6874